AT328459B - Verfahren zur herstellung von neuen 1,3,5-triazinen - Google Patents

Verfahren zur herstellung von neuen 1,3,5-triazinen

Info

Publication number
AT328459B
AT328459B AT1076673A AT1076673A AT328459B AT 328459 B AT328459 B AT 328459B AT 1076673 A AT1076673 A AT 1076673A AT 1076673 A AT1076673 A AT 1076673A AT 328459 B AT328459 B AT 328459B
Authority
AT
Austria
Prior art keywords
triazines
producing new
producing
new
Prior art date
Application number
AT1076673A
Other languages
English (en)
Other versions
ATA1076673A (de
Inventor
Gunter Dr Metz
Manfred Dr Specker
Original Assignee
Merckle Kg Chem Pharm L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Kg Chem Pharm L filed Critical Merckle Kg Chem Pharm L
Publication of ATA1076673A publication Critical patent/ATA1076673A/de
Application granted granted Critical
Publication of AT328459B publication Critical patent/AT328459B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1076673A 1972-12-22 1973-12-21 Verfahren zur herstellung von neuen 1,3,5-triazinen AT328459B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722263110 DE2263110B2 (de) 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
ATA1076673A ATA1076673A (de) 1975-06-15
AT328459B true AT328459B (de) 1976-03-25

Family

ID=5865287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1076673A AT328459B (de) 1972-12-22 1973-12-21 Verfahren zur herstellung von neuen 1,3,5-triazinen

Country Status (4)

Country Link
AT (1) AT328459B (de)
CH (1) CH598235A5 (de)
DE (1) DE2263110B2 (de)
GB (1) GB1384684A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526336A (en) * 2000-12-07 2004-11-26 Cv Therapeutics Inc Substituted 1, 3,5-triazines and pyrimidines as ABCA-1 elevating compounds against coronary artery disease or atherosclerosis
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors
US8940900B2 (en) * 2007-02-28 2015-01-27 Advinus Therapeutics Private Limited 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application

Also Published As

Publication number Publication date
ATA1076673A (de) 1975-06-15
DE2263110A1 (de) 1974-07-11
GB1384684A (en) 1975-02-19
DE2263110B2 (de) 1980-01-31
CH598235A5 (de) 1978-04-28
DE2263110C3 (de) 1980-09-18

Similar Documents

Publication Publication Date Title
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
AT329045B (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT342556B (de) Verfahren zur herstellung von neuen 1,2,2,2-tetrafluorathylathern
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT331806B (de) Verfahren zur herstellung von neuen 1,2,4-triazin-di-n-oxiden(1,4)
AT342564B (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT327902B (de) Verfahren zur herstellung von neuen 3,4-dihydropyridonen
AT326842B (de) Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten
AT328459B (de) Verfahren zur herstellung von neuen 1,3,5-triazinen
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT326673B (de) Verfahren zur herstellung von neuen 2-substituierten-4-alkylamino-6-(alpha,alpha-dimethyl-beta-acetyl-athylamino)-1,3,5-triazinen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT322739B (de) Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen
AT331203B (de) Verfahren zur herstellung von 1,2-dichlorathan
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT328631B (de) Verfahren zur herstellung von neuen 9,10-seco-ostran-derivaten
AT323345B (de) Verfahren zur herstellung von neuen 15 alfa, 16 alfa-methylen-5 alfa-androstanen
AT342025B (de) Verfahren zur herstellung von neuen 2- (alfa-di-substituierten-aminobenzyl) -propandiolen- (1,3)
AT335627B (de) Verfahren zur herstellung von neuen 3',4'-anhydro-alfa,l-talomethylosiden
AT323714B (de) Verfahren zur herstellung von neuen 6,9-dioxo-8-hydroxy-2-suestituierten-bicyclo-(3,3,1)-non-7-en-3-olen
ATA646772A (de) Verfahren zur herstellung von neuen substituierten n-carbamoyloxyphenylcarbamaten
AT331422B (de) Verfahren zur herstellung von neuen digitoxigenin-l-rhamnosid-cyclocarbonaten
AT327206B (de) Verfahren zur herstellung von neuen nitrochinazolinonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee